ALLO News and Press, Allogene Therapeutics Inc. From 07/26/23

2023-07-26 19:30:39 ET Summary Allogene Therapeutics, Inc. is the leading developer of allogeneic CAR-T. There was a time when its logic appealed to me. Lately, however, I have increasingly become disillusioned about its prospects. Lest we forget with all the C-suite...

Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET SOUTH SAN FRANCISCO, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for c...

2023-07-21 15:00:10 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar ...

2023-07-12 15:33:06 ET Summary Today we revisit SpringWorks Therapeutics, Inc. for the first time in nearly a year. The company's primary drug asset is on the cusp of garnering SpringWorks' first FDA approval for a rare affliction. An updated investment analysis follows in the...

2023-06-22 13:53:43 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Even with a proposed ban on short-selling stocks circulating among regulators, short interest isn’t slowing down. On the contrary, short bets from U.S. investors just reached their...

Presentation Includes Data on All 33 CAR T-Naïve Patients Treated with the Alloy™ Manufactured Material and Recaps Data on 12 Large B Cell Lymphoma Patients Treated with Phase 2 Dose Regimen Results Indicate an Off-the-Shelf Allogeneic CAR T Can Potentially Deliver Durable Complet...

2023-06-14 13:15:45 ET Gainers: WeTrade Group ( WETG ) +81% . SEALSQ Corp ( LAES ) +81% . Greenidge Generation Holdings ( GREE ) +49% . NextDecade Corporation ( NEXT ) +45% . WiSA Technologies ( WISA ) +31% . Vera Therapeutic...

2023-06-14 10:03:06 ET Gainers: Inventiva ( IVA ) +25% . Gossamer Bio ( GOSS ) +21% . Akoya Biosciences ( AKYA ) +19% . InVivo Therapeutics ( NVIV ) +14% . Bone Biologics ( BBLG ) +13% . Losers: IO Biotech ( IOBT ...

2023-06-14 08:08:34 ET Allogene Therapeutics ( NASDAQ: ALLO ) Chief Financial Officer, Eric T. Schmidt, Ph.D., will step down from his position on August 2, 2023 to spend more time with his family on the East Coast. The Company has initiated a search to fill this position. ...

SOUTH SAN FRANCISCO, Calif., June 14, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer, announced that its Chief Financial Officer, Eric T. Schmidt, Ph...